Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Mochida out-licenses type 2 diabetes treatment candidates

Dec. 13, 2011

Ono and Receptos join to discover novel GPCR-targeted therapeutics

Dec. 13, 2011

Abbott and Reata Pharmaceuticals enter new collaboration agreement

Dec. 13, 2011

Gedeon Richter gains extended marketing rights for Esmya

Dec. 12, 2011

Unigene Laboratories regains worldwide rights to oral PTH program

Dec. 12, 2011

Janssen Biotech and Pharmacyclics enter agreement for anticancer drug

Dec. 12, 2011

AtheroNova and Maxwell Biotech ratify agreement for AHRO-001

Dec. 7, 2011

Shire submits joint clinical trials proposal to confirm benefit of ProAmatine to FDA

Dec. 5, 2011

Tissue Therapies enters partnerships for wound care product

Dec. 5, 2011

Bristol-Myers Squibb collaborates with Tibotec Pharmaceuticals on phase II HCV trial

Dec. 5, 2011

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...